Lillian L. Siu

Also affiliated with Princess Margaret Cancer Centre

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer”.

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer

The Oncologist(2023)10.1093/oncolo/oyad210

N/A

0.250DataRank · unranked

3 citations

Rona Yaeger, Jean‐Pierre Delord, Josep Tabernero, Lillian L. Siu, Michel Ducreux +9 more

Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1412

N/A

0DataRank · unranked

8 citations

Eric Laille, Ulka N. Vaishampayan, Vincent Chung, Karen Kelly, Afshin Dowlati +16 more

Minimalist approaches to cancer tissue-of-origin classification by DNA methylation

Modern Pathology(2020)10.1038/s41379-020-0547-7

N/A

0DataRank · unranked

38 citations

Alberto J. León, Michael Cabanero, Trevor J. Pugh, Ming-Sound Tsao, Prisni Rath +8 more

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

Cancer(2020)10.1002/cncr.33145

N/A

0DataRank · unranked

62 citations

Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more

SARS-CoV-2 vaccination and phase 1 cancer clinical trials

The Lancet Oncology(2021)10.1016/s1470-2045(21)00017-6

N/A

0DataRank · unranked

12 citations

Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +5 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab015

N/A

0DataRank · unranked

56 citations

Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R. Abdul Razak, Anna Spreafico +5 more